{
  "id": "cluster_0_docid4",
  "content": "Internal audit reveals 14% of high-value claims in the Rome region lacked proper biomarker documentation from October-December 2023. Notable cases include at least five immunotherapy patients at Genovel Biocare where treatment authorization predated the new monitoring requirements. Claims processing was delayed an average of 18 days during policy transition.",
  "metadata": {
    "format": "audit_report"
  }
}